Webinar Discovery and development of EP652, A METTL3 Inhibitor with efficacy in liquid and Solid Tumour ModelsWe highlight computational analysis and modeling that facilitated in-silico design; providing a potent, active and tractable METTL3 inhibitor...
Webinar Computational approaches to prioritize macrocyclic designs for synthesisWe present a digital workflow that can be used to prioritize challenging ligands for synthesis
Case study Accelerating discovery of a METTL3 inhibitor through efficient in silico design and prioritizationCresset Discovery provides molecular modeling expertise utilizing the application of proprietary in silico methods which, when combined with...
